> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Priority Voucher Awarded to Bavarian Nordic
- URL: https://www.fdaweb.com/priority-voucher-awarded-to-bavarian-nordic/
- Published: 2019-10-09T12:00:00.000Z
- Updated: 2026-09-15T01:55:19.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5145205

*Federal Register* notice: FDA has announced that it has issued a material threat medical countermeasure priority review voucher to Bavarian Nordic for recently approved Jynneos (smallpox and monkeypox vaccine, live, non-replicating). The agency determined that the product met criteria for the priority review voucher because it is intended to prevent smallpox infection. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2019-10-09/pdf/2019-21984.pdf?ref=fdaweb.com).